The government shutdown isn't stopping Food and Drug Administration advisory committee meetings scheduled this month, according to drug and device manufacturers.
Some analysts warned that the shutdown could limit the FDA's panel discussions, postpone meetings and ultimately delay product launches and spook investors.
Read more »
